Workflow
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
CORCencora(COR) zacks.com·2024-05-27 12:46

Cencora, Inc. (COR) is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. COR currently reports under two segments — U.S. Healthcare Solutions and International Healthcare Solutions. The first segment comprises the legacy Pharmaceutical Distribution Services (excluding Proforma), MWI Animal Health, Xcenda, Lash Group and ICS 3PL. It benefits from an increasing volume and expanding customer base. Strong organic grow ...